These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32796488)

  • 1. Enhancing capacity and synthesis of [68Ga]68-Ga-PSMA-HBED-CC with the lyophilized ready-to-use kit for nuclear pharmacy applications.
    Golan H; Esa M; Moshkoviz K; Feldhaim A; Hoch B; Shalom E
    Nucl Med Commun; 2020 Sep; 41(9):986-990. PubMed ID: 32796488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Quality Control of the ITG 68Ge/68Ga Generator and Synthesis of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for Clinical Imaging.
    Amor-Coarasa A; Schoendorf M; Meckel M; Vallabhajosula S; Babich JW
    J Nucl Med; 2016 Sep; 57(9):1402-5. PubMed ID: 27103024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of [
    Kleynhans J; Rubow S; le Roux J; Marjanovic-Painter B; Zeevaart JR; Ebenhan T
    J Labelled Comp Radiopharm; 2020 Nov; 63(13):553-563. PubMed ID: 32865290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuation of comprehensive quality control of the itG
    Amor-Coarasa A; Kelly JM; Gruca M; Nikolopoulou A; Vallabhajosula S; Babich JW
    Nucl Med Biol; 2017 Oct; 53():37-39. PubMed ID: 28803001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of [(68)Ga]PSMA-11 for PET-CT imaging using a manual synthesis module and organic matrix based (68)Ge/(68)Ga generator.
    Nanabala R; Anees MK; Sasikumar A; Joy A; Pillai MR
    Nucl Med Biol; 2016 Aug; 43(8):463-9. PubMed ID: 27231953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of Labeling PSMA
    Eppard E; Homann T; de la Fuente A; Essler M; Rösch F
    J Nucl Med; 2017 Mar; 58(3):432-437. PubMed ID: 28082433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of the radiosynthesis of [68Ga]Ga-PSMA-11 using a Trasis MiniAiO synthesizer: do we need to heat and purify?
    Reverchon J; Khayi F; Roger M; Moreau A; Kryza D
    Nucl Med Commun; 2020 Sep; 41(9):977-985. PubMed ID: 32796487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, radiolabeling, and evaluation of gastrin releasing peptide receptor antagonist
    Satpati D; Vats K; Sharma R; Kameswaran M; Sarma HD; Dash A
    J Labelled Comp Radiopharm; 2019 Oct; 62(12):843-849. PubMed ID: 31378967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated radiosynthesis of [
    Wichmann CW; Ackermann U; Poniger S; Young K; Nguyen B; Chan G; Sachinidis J; Scott AM
    J Labelled Comp Radiopharm; 2021 Mar; 64(3):140-146. PubMed ID: 33067810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of
    Hofman MS; Eu P; Jackson P; Hong E; Binns D; Iravani A; Murphy D; Mitchell C; Siva S; Hicks RJ; Young JD; Blower PJ; Mullen GE
    J Nucl Med; 2018 Apr; 59(4):625-631. PubMed ID: 28986512
    [No Abstract]   [Full Text] [Related]  

  • 11. Validation of a [Al
    Al-Momani E; Israel I; Samnick S
    Appl Radiat Isot; 2017 Dec; 130():102-108. PubMed ID: 28950199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Shi S; Zhang L; Wu Z; Zhang A; Hong H; Choi SR; Zhu L; Kung HF
    Nucl Med Biol; 2020; 82-83():17-24. PubMed ID: 31869735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated production of [
    Garcia-Arguello SF; Lopez-Lorenzo B; Ruiz-Cruces R
    J Labelled Comp Radiopharm; 2019 Mar; 62(3):146-153. PubMed ID: 30672007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of
    Rodnick ME; Sollert C; Stark D; Clark M; Katsifis A; Hockley BG; Parr DC; Frigell J; Henderson BD; Bruton L; Preshlock S; Abghari-Gerst M; Piert MR; Fulham MJ; Eberl S; Gagnon K; Scott PJH
    Nat Protoc; 2022 Apr; 17(4):980-1003. PubMed ID: 35246649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiochemistry and Preclinical PET Imaging of
    Gourni E; Del Pozzo L; Bartholomä M; Kiefer Y; T Meyer P; Maecke HR; Holland JP
    Mol Imaging; 2017; 16():1536012117737010. PubMed ID: 29098927
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Vats K; Sharma R; Sarma HD; Satpati D; Dash A
    Anticancer Agents Med Chem; 2018; 18(9):1289-1294. PubMed ID: 29546835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of
    Guleria M; Amirdhanayagam J; Sarma HD; Rallapeta RP; Krishnamohan VS; Nimmagadda A; Ravi P; Patri S; Kalawat T; Das T
    Biomed Res Int; 2021; 2021():1555712. PubMed ID: 34845436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated synthesis of
    Sørensen MA; Andersen VL; Hendel HW; Vriamont C; Warnier C; Masset J; Huynh THV
    J Labelled Comp Radiopharm; 2020 Jun; 63(8):393-403. PubMed ID: 32374450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of
    Choi PS; Lee JY; Park JH; Kim SW
    J Labelled Comp Radiopharm; 2018 Jan; 61(1):4-10. PubMed ID: 28901564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 68Ga-PSMA-HBED-CC PET/CT imaging in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study.
    Lengana T; van de Wiele C; Lawal I; Maes A; Ebenhan T; Boshomane T; Zeevaart JR; Ankrah A; Mokgoro N; Vorster M; Sathekge M
    Nucl Med Commun; 2018 Feb; 39(2):179-185. PubMed ID: 29257006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.